(3S)-3-Amino-N-cyclopropyl-2-hydroxyhexanamide hydrochloride CAS 850252-34-5

Iden­ti­fi­ca­tion

CAS Number

850252-34-5

Name

(3S)-3-Amino-N-cyclo­propyl-2-hydrox­y­hexa­namide hydrochloride

Syn­onyms

(3S)-3-Amino-N-cyclo­propyl-2-hydrox­y­hexa­namide hydrochlo­ride (1:1) [ACD/IUPAC Name]
(3S)-3-Amino-N-cyclo­propyl-2-hydrox­y­hexa­namide, chlorhy­drate (1:1) [French] [ACD/IUPAC Name]
(3S)-3-Amino-N-cyclo­propyl-2-hydrox­y­hexa­namid­hy­drochlo­rid (1:1) [Ger­man] [ACD/IUPAC Name]
850252-34-5 [RN]
Hexa­namide, 3-amino-N-cyclo­propyl-2-hydroxy-, (3S)-, hydrochlo­ride (1:1) [ACD/​Index Name]
Hexa­namide, 3-amino-N-cyclo­propyl-2-hydroxy-, hydrochlo­ride (1:1), (3S)-
(3S)-3-Amino-N-cyclo­propyl-2-hydrox­y­hexa­namide hydrochlo­ride
(3S)-3-Amino-N-cyclo­propyl-2-hydroxy-hexa­namide hydrochlo­ride
(3S)-3-amino-N-cyclopropyl-2-hydroxyhexanamide;hydrochloride
(3S)-3-Amino-N-cyclo­propyl-2-hydrox­y­hexa­namide­hy­drochlo­ride
(3S)-3-Amino-N-cyclo­propyl-2-hydrox­y­hexa­namide – hydro­gen chlo­ride (1/1)
[850252-34-5] [RN]
CS-13257
MFCD21606965 [MDL number]

SMILES

CCC[C@@H](C(C(=O)NC1CC1)O)N.Cl

Std­InChI

InChI=1S/C9H18N2O2.ClH/c1-2-3-7(10)8(12)9(13)11-6-4-5-6;/h6-8,12H,2-5,10H2,1H3,(H,11,13);1H/t7-,8?;/m0./s1

Std­InChIKey

LMS­DLVWK­LI­IC­­SU-JPP­WUZRISA-N

Mol­e­c­u­lar Formula

C9H19ClN2O2

Mol­e­c­u­lar Weight

222.712

MDL Number

MFCD21606965

Prop­er­ties

Appear­ance

White to off-white (Sol­id)

Safe­ty Data

Sym­bol

exclamation-mark-jpgGHS07

Sig­nal Word

Warn­ing

Haz­ard statements

H302, H315, H319H335

Pre­cau­tion­ary Statements

P261, P305, P338P351

WGK Germany

3

MSDS Download

Spec­i­fi­ca­tions and Oth­er Infor­ma­tion of Our 

Iden­ti­fi­ca­tion Methods

HNMR, HPLC

Puri­ty

99% min

Shelf Life

1 year

Stor­age

Under room tem­per­a­ture away from light

Known Appli­ca­tion

(3S)-3-Amino-N-cyclo­propyl-2-hydrox­y­hexa­namide hydrochlo­ride (CAS 850252-34-5) is an impor­tant inter­me­di­ate in the syn­the­sis of Telapre­vir. Telapre­vir is a pro­tease inhibitor used in the treat­ment of hepati­tis C virus (HCV) infec­tion.

Gen­er­al View of Documents

This prod­uct is devel­oped by our R&D com­pa­ny Cam­ing Phar­ma­ceu­ti­cal Lim­it­ed (http://​www​.cam​ing​.com/).

Quick Inquiry

Fill out our inquiry form and one of our experts will be in touch with you shortly.

























    Please prove you are human by select­ing the heart.